Browse by Section 100 Item List

Highly Specialised Drugs Program (Private Hospital)

For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through private hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in private hospitals are Authority Required items. Application for authorisation can be made by either:

  • posting an Authority Prescription form and other application form(s), where applicable to Services Australia
  • using the form upload facility in Health Professional Online Services (HPOS)
  • using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
  • using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
  • using the appropriate Streamlined code.

Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.

Private hospital prescriptions for Highly Specialised Drugs can be dispensed by an approved private hospital dispensary or by a community pharmacy. A patient will be required to pay a contribution for each supply of a highly specialised drug at the same rate as the PBS.

The remuneration rates for Highly Specialised Drugs prescribed through private hospitals comprise the normal PBS ready-prepared dispensing fee plus a mark-up ascertained as follows:

  • 10% for drugs with an ex-manufacturer price of less than $40
  • $4 for drugs with an ex-manufacturer price of between $40 and $100
  • 4% for drugs with an ex-manufacturer price of between $100.01 and $1000
  • $40 for drugs with an ex-manufacturer price of greater than $1000.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 12897T RAVULIZUMABravulizumab 1.1 g/11 mL injection, 11 mL vial 1 1 2
MP 12901B RAVULIZUMABravulizumab 1.1 g/11 mL injection, 11 mL vial 1 1 0
MP 13784L RAVULIZUMABravulizumab 1.1 g/11 mL injection, 11 mL vial 1 1 2
MP 13802K RAVULIZUMABravulizumab 1.1 g/11 mL injection, 11 mL vial 1 1 0
MP 12841W RAVULIZUMABravulizumab 300 mg/3 mL injection, 3 mL vial 1 1 0
MP 12895Q RAVULIZUMABravulizumab 300 mg/3 mL injection, 3 mL vial 1 1 2
MP 13786N RAVULIZUMABravulizumab 300 mg/3 mL injection, 3 mL vial 1 1 2
MP 13791W RAVULIZUMABravulizumab 300 mg/3 mL injection, 3 mL vial 1 1 0
MPNP 12809E RIBAVIRINribavirin 200 mg tablet, 100 2 200 2
MPNP 6195C RIFABUTINrifabutin 150 mg capsule, 30 4 120 5
MP 11009K RIOCIGUATriociguat 500 microgram tablet, 42 1 42 0
MP 11031N RIOCIGUATriociguat 500 microgram tablet, 42 1 42 0
MP 10990K RIOCIGUATriociguat 1 mg tablet, 42 1 42 0
MP 11028K RIOCIGUATriociguat 1 mg tablet, 42 1 42 0
MP 10974N RIOCIGUATriociguat 1.5 mg tablet, 42 1 42 0
MP 11046J RIOCIGUATriociguat 1.5 mg tablet, 42 1 42 0
MP 11012N RIOCIGUATriociguat 2 mg tablet, 42 1 42 0
MP 11045H RIOCIGUATriociguat 2 mg tablet, 42 1 42 0
MP 10985E RIOCIGUATriociguat 2.5 mg tablet, 42 1 42 0
MP 11052Q RIOCIGUATriociguat 2.5 mg tablet, 42 1 42 0
MP 12609P RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 5
MP 12610Q RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 0
MP 12959C RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 0
MP 13632L RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 3 3 7
MP 13639W RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 3 3 5
MP 13646F RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 3 3 5
MP 13647G RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 0
MP 13659X RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 3 3 5
MP 13109Y RITUXIMABrituximab 100 mg/10 mL injection, 10 mL vial 6 6 0
MP 13096G RITUXIMABrituximab 100 mg/10 mL injection, 2 x 10 mL vials 3 6 0
MP 13095F RITUXIMABrituximab 500 mg/50 mL injection, 50 mL vial 2 2 1
MP 9697J ROMIPLOSTIMromiplostim 250 microgram injection, 1 vial 1 1 5
MP 9699L ROMIPLOSTIMromiplostim 500 microgram injection, 1 vial 1 1 5
MP 13239T RUXOLITINIBruxolitinib 5 mg tablet, 56 1 56 0
MP 13244C RUXOLITINIBruxolitinib 5 mg tablet, 56 1 56 5
MP 13231J RUXOLITINIBruxolitinib 10 mg tablet, 56 1 56 5
MP 13236P RUXOLITINIBruxolitinib 10 mg tablet, 56 1 56 0